Skip to main content

Table 4 Prevalence and odds ratios (OR) with 95% confidence intervals of previously known type 2 diabetes (T2D), screen-detected type 2 diabetes (ST2D), total type 2 diabetes (TT2D), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), abnormal glucose tolerance (AGT = TT2D, IGT or IFG) of the study sample by waist circumference and gender

From: High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population

  MEN WOMEN
  WAIST CIRCUMFERENCE (cm) WAIST CIRCUMFERENCE (cm)
  < 94 94–101 = 102 p* < 80 80–87 = 88 p*
n 427 437 500   351 355 755  
T2D, % 2.1 5.5 15.2 < 0.001 2.0 2.5 6.9 < 0.001
OR 1.0 (ref) 2.50
(1.14–5.47)
7.92
(3.89–16.11)
  1.0 (ref) 1.20
(0.44–3.28)
3.12
(1.39–6.98)
 
ST2D, % 5.2 7.8 14.0 < 0.001 2.3 3.7 11.8 < 0.001
OR 1.0 (ref) 1.46
(0.83–2.55)
2.69
(1.63–4.46)
  1.0 (ref) 1.56
(0.63–3.82)
5.00
(2.39–10.49)
 
TT2D, % 7.3 13.3 29.2 < 0.001 4.3 6.2 18.7 < 0.001
OR 1.0 (ref) 1.82
(1.14–2.89)
4.93
(3.24–7.51)
  1.0 (ref) 1.40
(0.71–2.77)
4.48
(2.57–7.80)
 
IGT, % 9.6 18.1 19.6 < 0.001 8.8 15.2 21.2 < 0.001
OR 1.0 (ref) 1.92
(1.28–2.90)
2.01
(1.35–3.00)
  1.0 (ref) 1.82
(1.13–2.93)
2.50
(1.65–3.79)
 
IFG, % 6.3 8.0 13.2 < 0.001 0.9 4.8 6.8 < 0.001
OR 1.0 (ref) 1.36
(0.80–2.29)
2.46
(1.53–3.96)
  1.0 (ref) 5.97
(1.73–20.57)
8.71
(2.69–28.20)
 
AGT, % 23.2 39.4 62.0 < 0.001 14.0 26.2 46.6 < 0.001
OR 1.0 (ref) 2.05
(1.51–2.79)
5.23
(3.87–7.05)
  1.0 (ref) 2.18
(1.47–3.23)
5.02
(3.56–7.08)
 
  1. *Likelihood-ratio test of equality, adjusted for age. †Age and geographical area adjusted odds ratios including 95% confidence interval of odds ratios.
\